Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Mar 8;114(3):345-346.
doi: 10.1093/jnci/djab061.

On the Quest of Risk Stratification in HER2-Positive Breast Cancer

Mei-Yin C Polley  1
Affiliations
Editorial

On the Quest of Risk Stratification in HER2-Positive Breast Cancer

Mei-Yin C Polley. J Natl Cancer Inst. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. von Minckwitz G, Untch M, Blohmer JU, et al.Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol. 2012;30(15):1796–1804. - PubMed
    1. Cortazar P, Zhang L, Untch M, et al.Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384(9938):164–172. - PubMed
    1. Broglio KR, Quintana M, Foster M, et al.Association of pathologic complete response to neoadjuvant therapy in HER2-positive breast cancer with long-term outcomes: a meta-analysis. JAMA Oncol. 2016;2(6):751–760. - PubMed
    1. Chic N, Luen SJ, Nuciforo P, et al.Tumor cellularity and infiltrating lymphocytes (CelTIL) as a survival surrogate in HER2-positive breast cancer. J Natl Cancer Inst. 2021. - PMC - PubMed
    1. Polley MY, Freidlin B, Korn EL, et al.Statistical and practical considerations for clinical evaluation of predictive biomarkers. J Natl Cancer Inst. 2013;105(22):1677–1683. - PMC - PubMed